---
title: Direct-to-biology, automated, nano-scale synthesis, and phenotypic screening-enabled
  E3 ligase modulator discovery
date: '2023-12-19'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38114468/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20231220170721&v=2.18.0
source: heidelberg[Affiliation]
description: Thalidomide and its analogs are molecular glues (MGs) that lead to targeted
  ubiquitination and degradation of key cancer proteins via the cereblon (CRBN) E3
  ligase. Here, we develop a direct-to-biology (D2B) approach for accelerated discovery
  of MGs. In this platform, automated, high throughput, and nano scale synthesis of
  hundreds of pomalidomide-based MGs was combined with rapid phenotypic screening,
  enabling an unprecedented fast identification of potent CRBN-acting MGs. The small
  ...
disable_comments: true
---
Thalidomide and its analogs are molecular glues (MGs) that lead to targeted ubiquitination and degradation of key cancer proteins via the cereblon (CRBN) E3 ligase. Here, we develop a direct-to-biology (D2B) approach for accelerated discovery of MGs. In this platform, automated, high throughput, and nano scale synthesis of hundreds of pomalidomide-based MGs was combined with rapid phenotypic screening, enabling an unprecedented fast identification of potent CRBN-acting MGs. The small ...